Woodline Partners LP Insulet Corp Transaction History

Woodline Partners LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$272.48 - $330.23 $2.64 Million - $3.2 Million	9,677 New	9,677 $2.79 Million
Q4 2022 Feb 14, 2023	BUY	$212.22 - $313.46 $3.73 Million - $5.51 Million	17,569 New	17,569 $5.17 Million
Q3 2021 Nov 15, 2021	SELL	$260.36 - $307.27 $3.16 Million - $3.73 Million	-12,148 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$225.52 - $304.06 $3.18 Million - $4.29 Million	-14,098 Reduced 53.71%	12,148 $3.34 Million
Q1 2021 May 17, 2021	BUY	$235.95 - $293.05 $6.19 Million - $7.69 Million	26,246 New	26,246 $6.85 Million

687

62.6M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.3B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.